EGFRvIII peptide

SKU: orb2563638

Description

This peptide, derived from the EGFRvIII mutant protein and presented by MHC I, can be used in glioblastoma research. When administered alone or conjugated with Flagellin B, it induces apoptosis and stimulates targeted immune responses in both in vitro and in vivo experimental models.

Research Area

Cell Biology

Images & Validation

−

Key Properties

−

Target	Apoptosis
CAS Number	916850-24-3
MW	1079.20
Formula	C₄₈H₇₈N₁₂O₁₆
SMILES	[C@@H](CC1=CC=C(O)C=C1)(NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(C)C)N)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCCCN)=O)CCCCN)=O)=O)CC(N)=O)=O)C(N[C@@H]([C@@H](C)C)C(O)=O)=O

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

171361393 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Protein Handling and Storage Guide

Protein Handling Guide

View Guide

Find More Protocols